Jonathan E Volk
Datos Biográficos
| ID | 6070520 |
|---|---|
| NOMBRE | Jonathan E Volk |
| NOMBRES | Jonathan E |
| APELLIDO | Volk |
| FIRMA | VOLK J E |
| AFILIACIONES | Kaiser Permanente San Francisco Medical Center |
| VERIFICADO | No |
| TOTAL DE OBRAS | 9 |
| TOTAL DE CITAS | 3 |
| TOTAL COMO AUTOR | 9 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2003 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2019 |
| ÍNDICE H | 1 |
Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California
Barriers to HIV preexposure prophylaxis (PrEP) use have not been well-characterized in people who became HIV-infected, all of whom could have benefited from PrEP. We invited Kaiser Permanente Northern California members diagnosed with HIV during 2014-2016, following a negative HIV test in the prior year, to complete a survey assessing barriers to PrEP use before HIV diagnosis. Of 268 patients surveyed, 122 (46%) responded. Median age was 36, most…
Low-Intensity Outreach to Increase Uptake of HIV Preexposure Prophylaxis Among Patients with Sexually Transmitted Infections
Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men
Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System
BACKGROUND: Placebo-controlled and open-label studies have demonstrated the safety and efficacy of daily oral preexposure prophylaxis (PrEP) in preventing HIV infection, but data are limited on real-world PrEP use. METHODS: We conducted a cohort study from July 2012 through June 2015 of Kaiser Permanente Northern California members initiating PrEP. We assessed pharmacy refill adherence and discontinuation, decreases in estimated glomerular filtra…
Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System
"Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System." , 106(10), pp. e2–e3
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting
Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population.
HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran
This study explored the prevalence and related risk behaviors for hepatitis C (HCV), hepatitis B (HBV), and human immunodeficiency virus (HIV) among a sample of male injection drug users (IDUs) in Arak, Iran. One hundred male IDUs attending methadone maintenance clinics between April and September 2012 were enrolled and evaluated for HCV, HBV, and HIV infection. The majority of study participants (56%) had evidence of HCV exposure, 6% had evidenc…
How Can We Improve Online HIV and STD Prevention for Men Who Have Sex with Men? Perspectives of Hook-Up Website Owners, Website Users, and HIV/STD Directors
Why HIV Infections Have Increased Among Men Who Have Sex with Men and What to Do About It
Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System
"Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System." , 106(10), pp. e2–e3
Why HIV Infections Have Increased Among Men Who Have Sex with Men and What to Do About It
How Can We Improve Online HIV and STD Prevention for Men Who Have Sex with Men? Perspectives of Hook-Up Website Owners, Website Users, and HIV/STD Directors
HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran
This study explored the prevalence and related risk behaviors for hepatitis C (HCV), hepatitis B (HBV), and human immunodeficiency virus (HIV) among a sample of male injection drug users (IDUs) in Arak, Iran. One hundred male IDUs attending methadone maintenance clinics between April and September 2012 were enrolled and evaluated for HCV, HBV, and HIV infection. The majority of study participants (56%) had evidence of HCV exposure, 6% had evidenc…
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting
Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population.
Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System
BACKGROUND: Placebo-controlled and open-label studies have demonstrated the safety and efficacy of daily oral preexposure prophylaxis (PrEP) in preventing HIV infection, but data are limited on real-world PrEP use. METHODS: We conducted a cohort study from July 2012 through June 2015 of Kaiser Permanente Northern California members initiating PrEP. We assessed pharmacy refill adherence and discontinuation, decreases in estimated glomerular filtra…
Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System
"Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System." , 106(10), pp. e2–e3
Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men
Low-Intensity Outreach to Increase Uptake of HIV Preexposure Prophylaxis Among Patients with Sexually Transmitted Infections
Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California
Barriers to HIV preexposure prophylaxis (PrEP) use have not been well-characterized in people who became HIV-infected, all of whom could have benefited from PrEP. We invited Kaiser Permanente Northern California members diagnosed with HIV during 2014-2016, following a negative HIV test in the prior year, to complete a survey assessing barriers to PrEP use before HIV diagnosis. Of 268 patients surveyed, 122 (46%) responded. Median age was 36, most…
Medicine (9 obras) · HIV/AIDS Research and Interventions (8 obras) · Men who have sex with men (8 obras) · Family medicine (7 obras) · HIV, Drug Use, Sexual Risk (7 obras) · Syphilis (6 obras) · Pre-exposure prophylaxis (5 obras) · Environmental health (4 obras) · Health psychology (4 obras) · Human immunodeficiency virus (HIV) (4 obras)